Sector dividends Perspective Therapeutics, Inc.
Stocks
CATX
US46489V3024
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.950 USD | -8.39% |
|
-7.10% | +7.09% |
| Jul. 08 | Perspective Therapeutics, Inc. Announces Executive Changes | CI |
| Jul. 08 | Perspective Therapeutics Names Paul Lyne Chief Science Officer as Co-Founder Michael Schultz Moves to Advisory Role | MT |
Main competitors
| Dividend Yield (N) | Dividend Yield (N+1) | P/E (N) | Price to Book (N) | EV / Sales (N) | EV / EBITDA (N) | EV / EBIT (N) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| -.--% | -.--% | -2.9x | 1.43x | 431.15x | -1.42x | -1.44x | 367M | ||
| 0.94% | 1.07% | 35.1x | 4.46x | 6.14x | 18.98x | 26.35x | 50.35B | ||
| -.--% | -.--% | -23.1x | 18.16x | 337.19x | -21.24x | -21.08x | 39.21B | ||
| -.--% | -.--% | 25.17x | 4.77x | 2.79x | 12.05x | 18.36x | 34.52B | ||
| -.--% | -.--% | 46.88x | 6.97x | 4.72x | 30.24x | 34.98x | 34.6B | ||
| 0.42% | 0.46% | 27.13x | 2.22x | 7.96x | 19.97x | 23.43x | 27.05B | ||
| -.--% | -.--% | 31.25x | 15.55x | 5.03x | 22.91x | 24.01x | 15.11B | ||
| 1.11% | 1.3% | 24.07x | 2.52x | 2.05x | 9x | 14.23x | 13.85B | ||
| -.--% | -.--% | 24.32x | 1.36x | 1.93x | 11.7x | 13.29x | 13.18B | ||
| -.--% | -.--% | -32.78x | 9.94x | 125.28x | -35.66x | -62.05x | 11.81B | ||
| -.--% | -.--% | 37.23x | 3.33x | 3.33x | 12.93x | 15.78x | 10.99B | ||
| 0.45% | 0.45% | 61.36x | 5.13x | 9.16x | 26.02x | 28.45x | 11.14B | ||
| -.--% | -.--% | -28.97x | 25.33x | 6.86x | 167.52x | -501.88x | 10.28B | ||
| -.--% | -.--% | -31.11x | 9x | 999.38x | -26.49x | -25.96x | 10.06B | ||
| -.--% | -.--% | -32.39x | 8.34x | 95.29x | -21.38x | -20.62x | 9.39B | ||
| 0.6% | 0.72% | 36.01x | 4.17x | 4.41x | 18.54x | 28.74x | 9.94B | ||
| -.--% | -.--% | -20.97x | 7.93x | 2918.62x | -17.67x | -17.23x | 8.88B | ||
| -.--% | -.--% | -15.14x | 219.2x | 9.89x | -14.63x | -13.88x | 9.04B | ||
| -.--% | -.--% | -135.5x | 4.69x | 5.35x | 30.51x | 169.62x | 8.66B | ||
| Average | 0.19% | 0.21% | 1.35x | 18.66x | 261.92x | 12.73x | -14.05x | 17.29B | |
| Weighted average by Cap. | 0.26% | 0.29% | 11.76x | 13.60x | 161.44x | 12.71x | -2.03x |
- Stock Market
- Stocks
- CATX Stock
- Sector Perspective Therapeutics, Inc.
- Sector dividends
Select your edition
All financial news and data tailored to specific country editions
















